Jack Richard Eastridge

Title: Jack Richard Eastridge: Innovator in Antimycotic Lipopeptide Compounds

Introduction

Jack Richard Eastridge is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of microbiology, particularly in the production of unique antimycotic compounds. With a total of 2 patents, Eastridge's work has implications for both human and plant health.

Latest Patents

Eastridge's latest patents include innovative methods for producing pseudomycins. The first patent describes a method for producing one or more pseudomycins using cultures of Pseudomonas syringae, which have a general formula where R is a lipophilic moiety. The second patent focuses on a family of unique antimycotic lipopeptide compounds produced by Pseudomonas syringae. These lipopeptides are effective against various fungal pathogens and are characterized by their ability to inhibit growth. Representative lipopeptides from this invention have molecular weights of 1137, 1153, 1164, and 1181 daltons.

Career Highlights

Eastridge is currently associated with Eli Lilly and Company, where he continues to advance his research in the field of antimycotic compounds. His work has garnered attention for its potential applications in treating fungal infections.

Collaborations

Eastridge has collaborated with notable colleagues, including Matthew Dale Hilton and Robert Joseph Strobel, Jr. These collaborations have contributed to the development of his innovative patents.

Conclusion

Jack Richard Eastridge is a prominent inventor whose work in antimycotic lipopeptide compounds has the potential to impact both human and plant health significantly. His contributions to the field are noteworthy and continue to inspire further research and innovation.